TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
MRNA

Moderna Inc

Healthcare · Biotechnology

158.10$ +8.5% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement MRNA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-100.0% +89.9% -40.5% -60.8% +471.4% +6,361.4% +6.4% -63.7% -53.3% -39.2%
+35.9% +2,111.0% +9.3% -98.4% +32,888.8% +107.0% -13.3% -68.8% -40.7%
-100.0% +98.6% -278.9% +454.9% +5,572.0% -11.0% -84.0% -19.5% -38.0%
-53.0% +85,131.9% +49.4% +10.6% +9.3% +176.1% +45.3% +65.5% +47.0% -6.2% -31.1%
-76.4% +7,216.0% +12.7% +45.6% +16.3% +71.7% +201.2% +78.3% +33.0% -23.6% -1.0%
+28,525.8% +43.4% +17.8% +10.8% +73.4% +77.0% +121.6% +58.3% -11.2% -26.9%
-29.2% -145.0%
+2,245.5% +113.6% +49.5% +82.1% +61.1% +31.0% -36.8% -58.3%
-27.9% -141.2%
+65,087.5% -107.7% -313.2% +42,353.9% +12.0% -36.4% -106.0%
-31.5% -156.4%
-26.4% -133.0%

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?